The independent source for health policy research, polling, and news.
Parents of students with legitimate learning disabilities worry that a backlash against providing special accommodations in college admissions testing could make it harder for them to succeed.
A federal district judge appeared skeptical of the arguments by the Justice Department and Arkansas and Kentucky that their programs should mandate that some enrollees work.
New research shows that older adults want close relationships with the people they care about and meaningful social roles.
Well-known insurers are offering plans with lower premiums. But they could leave patients on the hook for unexpected costs.
Confronting changing health care needs, fixed incomes and problems created by climate change can be overwhelming when trying to pinpoint that dream location, but taking time and doing research makes it a dream come true, say these seniors.
The budget would increase funding for efforts like the state-centered initiatives run by the Centers for Disease Control and the Ryan White Program, which offers services and treatment to patients. But it would also dramatically cut funding for global HIV efforts.
Outbreaks of infectious diseases such as typhus and hepatitis A are resurging in California and around the country, particularly among homeless populations. Public health officials warn that such diseases could spread broadly.
At recent “barnstorming” meetings in South Carolina and West Virginia, activists felt momentum behind their “Medicare-for-all” cause even as they ready for a major political fight.
Eli Lilly released a half-price generic version of its own short-acting insulin. At $137.35 per vial, the generic insulin is priced at about the same level as Humalog was in 2012.
Details of the reductions have not yet been announced, but in 2017 Congress ordered mandated changes to make the military health system more efficient.
More than 275 people — mostly in Orthodox Jewish communities — have been infected since the disease began spreading in October. That’s about half of the confirmed cases in 11 states that were reported nationwide by the federal officials since January 2018.
The FDA said it might reclassify the widely used devices featured in a recent Kaiser Health News investigation.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Millennials and Gen Zers say they often feel isolated even when surrounded by friends — both real and virtual.
Most hospitals appear to be complying with the federal rule to post their prices online. Yet there is little follow-up by the government or industry and debate continues about whether the price lists are creating more confusion than clarity among consumers.
Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare program.
Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss the resignation of Food and Drug Administration Commissioner Scott Gottlieb, the latest on federal and state efforts to shore up the Affordable Care Act; and how public health officials plan to persuade parents who are reluctant to vaccinate their kids. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.
The Food and Drug Administration has let medical device companies file reports of injuries and malfunctions outside a widely scrutinized public database, leaving doctors and medical sleuths in the dark.
A recent outbreak at a Louisiana center triggered public health protections, but some immigration lawyers are crying foul.
The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.
